Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.

doi:10.1002/ajh.70279

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.

American journal of hematology - 1 Jun 2026

Gillis Nancy, Colin-Leitzinger Christelle, Tang Yi-Han, Otterstatter Michael, Sherman Seth, Zhang Ling, Moscinski Lynn C, Walker Mary Ellen, Painter Jeffrey S, Abel Gregory A, Al Baghdadi Tareq, Deeg H Joachim, Foran James M, Gore Steven D, Harrington Alexandra M, Kroft Steven H, Liu Jane Jijun, Saber Wael, Virani Shamsuddin, Bejar Rafael, Lindsley R Coleman, Padron Eric, Walter Matthew J, Komrokji Rami, DeZern Amy E, Sekeres Mikkael A

Abstract excerpt

The epidemiology of myelodysplastic syndromes/neoplasms (MDS) is challenging to define due to inconsistent reporting, complex diagnostic procedures, and evolving diagnostic criteria. Using the National MDS Natural History Study-a prospective cohort with centrally adjudicated histopathology and genetic variant review-we characterized the landscape of MDS across the United States and identified differences across...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Black or African American

Share to Hispanic or Latino

Share to Myelodysplastic Syndromes

Share to Sex Factors

Share to United States

Share to White

Source

Open in PubMed Open full text

Identifiers

PMID: 41906220
DOI: 10.1002/ajh.70279
PMCID: PMC13139886

Genes

ASXL1
DNMT3A
SF3B1
SRSF2
TET2
TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.PMID 41906220Read ↗

Epidemiology and Pathogenesis of Myelodysplastic Syndrome.Semantic proximity Read ↗

Myelodysplastic syndromes: Updates on Genomic Landscape, Molecular Subtypes, & Targeted Therapies.Semantic proximity Read ↗

Diagnosis and classification of myelodysplastic syndromesSemantic proximity Read ↗

The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm.Semantic proximity Read ↗

Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.Semantic proximity Read ↗

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study.Semantic proximity Read ↗

Molecular taxonomy of myelodysplastic syndromes and its clinical implications.Semantic proximity Read ↗

Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative NeoplasmsSemantic proximity Read ↗

A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms.Semantic proximity Read ↗

Diagnostics and Prognostication of Myelodysplastic SyndromesSemantic proximity Read ↗

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.